Horizon Pharma reports small Q2 profit

Horizon Pharma ($HZNP), which is trying to buy Depomed ($DEPO), today reported a small profit for Q2. It said sales soared 161%, hitting $172.8 million as revenues from newly acquired products kicked in. Horizon has offered $2 billion for Depomed, but Depomed says it has been promised a higher offer from its pursuer. Release | More